Comparison

Professional Data Portfolio vs AngioAID 3D

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

Professional Data Portfolio

Features
Read full description

The Professional Data Portfolio helps physicians track their clinical performance data and continuing education needed for maintenance of certification and licensure. Clinical performance data aids participation in clinical practice improvement efforts while also providing practice administrators a way to manage physicians’ quality improvement activities, submit evidence of completion to various medical boards to maintain MOC and receive reimbursement through the CMS Merit-based Incentive System (MIPS) . Continuing education is tracked through credit trackers. Using a member’s ACC transcript, the tracker will plot the credits/points earned against a clinicians certification and licensure requirements. Key features include: •         A mobile-friendly view of NCDR clinical performance data to review and track ongoing quality performance. •         Ability to create, track progress, and document implementation of self-guided clinical quality activities based on NCDR data. •         Ability to submit clinical practice improvement activities to medical specialty boards for MOC credit. •         Ability to submit improvement activities to CMS’ MIPS program for reimbursement. • Create and track your continuing education credits and/or maintenance of certification points needed for certification and licensure.

About

AngioAID 3D

An interactive 3D simulation for learning diagnostic angiography of coronary arteries. Practice advancing catheters, manipulating views, and injecting dye in a realistic environment. Includes review modes with key anatomical and procedural information.

Highlights
  • 3D live simulation of coronary angiography
  • Interactive guidewire and catheter manipulation
  • Hemodynamic monitoring
  • C-Arm angle adjustment
  • Dye injection and cine comparison
  • Review Mode with anatomical insights
  • Tutorial video
Features
Read full description

AngioAID 3D is educational tool designed to teach key concepts of diagnostic angiography of coronary arteries. Developed at the Mount Sinai Hospital in New York City, New York State's highest volume cardiac cath lab, we aim to provide an interactive learning experience on this important topic. Within a 3D live simulation, you begin by advancing a diagnostic guidewire into the aortic root. Then, advance one of many diagnostic catheter options to either the right of left coronary ostium. Through pushing and pulling, as well as rotation of the catheter, try to achieve a truly co-axial engagement of the coronary ostium with the catheter. Meanwhile monitor the hemodynamic tab which simulated damping from over-engagement or roofing of the catheter tip. Line up the view with the target view, zoom to fill the screen with he coronaries, and rotate the C-Arm LAO/RAO and Cranial/Caudal until you're where you think you need to be. Finally, inject dye and take a cine to compare with the one we actually did in the cath lab for this set of coronaries. In addition to the diagnostic simulation, "Review Mode" allows you to play with angles and panning while always being able to see the vessels with no dye injection needed. Also a collection of key topics have been included within the review mode such as key angiographic angles depending on what you're aiming to see clearly, vessel segmentation conventions, and more coronary anatomy and angiography pearls. We highly recommend you view the tutorial video that is available when you first open the application or from the settings page to understand all of the available functions. The first launch has a normal set of coronary arteries but please stay tuned while we create more sets of coronaries such as anomalous coronaries and bypass grafts.

Screenshots

Professional Data Portfolio4 screens
AngioAID 3D4 screens

Verdict

The call

The clearest difference is ads: Professional Data Portfolio at none against AngioAID 3D's shown. Professional Data Portfolio also leads on update cadence (every 13 months vs every 28 months) and iOS requirement (13.0 vs 15.0). On price, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

Professional Data Portfolio ships an update every 13 months, AngioAID 3D every 28 months. The most recent releases landed on October 26, 2026 and October 11, 2026 respectively.

Scorecard3 real differences · 6 level
Professional Data Portfolio versus AngioAID 3D: the parameters behind the verdict, then further details
ParameterProfessional Data PortfolioAngioAID 3D
PriceFreeFree
Rating—4.0 (1 ratings) — better
Number of ratings—1 — better
Update frequencyEvery 13 months — betterEvery 28 months
AdsNo — betterYes
In-app purchasesNoNo
Monetization—Ad-supported
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS13.0 — better15.0
Further details — not scored
Size45 MB92 MB
Age rating17+17+
DeveloperAmerican College of CardiologyCardiology Apps LLC

In-app purchases

None

Professional Data Portfolio

No in-app purchases

None

AngioAID 3D

No in-app purchases

Questions

Is Professional Data Portfolio free?
Professional Data Portfolio is free to download, with no in-app purchases.
Is AngioAID 3D free?
AngioAID 3D is free to download, with no in-app purchases.
Do Professional Data Portfolio or AngioAID 3D have ads?
AngioAID 3D shows ads; Professional Data Portfolio does not.
Which is updated more often, Professional Data Portfolio or AngioAID 3D?
Professional Data Portfolio ships an update every 13 months, and AngioAID 3D every 28 months. Most recently, Professional Data Portfolio was updated on October 26, 2026 and AngioAID 3D on October 11, 2026.

Other comparisons